CNS Pharmaceuticals Inc
General ticker "CNSP" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $2.4M
CNS Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -35.8%.
Estimated limits based on current volatility of 7.1%: low 0.10$, high 0.12$
Factors to consider:
- Current price 99.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [17.32$, 95.64$]
- 2024-12-30 to 2025-12-30 estimated range: [5.83$, 33.50$]
Financial Metrics affecting the CNSP estimates:
- Negative: Non-GAAP EPS, $ of -52.21 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -67.86 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
Short-term CNSP quotes
Long-term CNSP plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $14.49MM | $15.27MM | $18.87MM |
| Operating Income | $-14.49MM | $-15.27MM | $-18.87MM |
| Non-Operating Income | $-0.02MM | $-0.01MM | $0.01MM |
| Interest Expense | $0.01MM | $0.01MM | $0.00MM |
| R&D Expense | $9.35MM | $9.30MM | $14.10MM |
| Income(Loss) | $-14.50MM | $-15.28MM | $-18.85MM |
| Profit(Loss) | $-14.50MM | $-15.28MM | $-18.85MM |
| Stockholders Equity | $6.16MM | $8.13MM | $-4.43MM |
| Assets | $8.76MM | $13.05MM | $1.70MM |
| Operating Cash Flow | $-13.54MM | $-10.56MM | $-14.14MM |
| Capital expenditure | $0.01MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.01MM | $-0.00MM | $-0.00MM |
| Financing Cash Flow | $4.51MM | $15.61MM | $4.64MM |
| Earnings Per Share* | $-852.66 | $-560.83 | $-251.35 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.